Magnetic resonance venography to assess thrombus resolution with edoxaban monotherapy versus parenteral anticoagulation/warfarin for symptomatic deep vein thrombosis: A multicenter feasibility study

Vascular Medicine (United Kingdom)

Volumn 21, Issue 4, 2016, Pages 361-368

  Piazza, Gregory ^a   Mani, Venkatesh ^b   Goldhaber, Samuel Z ^a   Grosso, Michael A ^c   Mercuri, Michele ^c   Lanz, Hans J ^c   Schussler, Steven ^c   Hsu, Ching ^c   Chinigo, Amy ^c   Ritchie, Bruce ^d   Nadar, Venkatesh ^e   Cannon, Kevin ^f   Pullman, John ^g   Concha, Mauricio ^h   Schul, Marlin ⁱ   Fayad, Zahi A ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c DAIICHI SANKYO INC   (United States)

^d UNIVERSITY OF ALBERTA   (Canada)

^e Lewin and Nadar Cardiology Ass   (United States)

^f Wilmington Health Associates   (United States)

^g St James Healthcare   (United States)

^h Intercoastal Medical Group   (United States)

ⁱ Lafayette Regional Vein Center   (United States)

Author keywords

anticoagulation; deep vein thrombosis; edoxaban; magnetic resonance; MRV; venous thromboembolism eTRIS

Indexed keywords

EDOXABAN; WARFARIN; ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 10A INHIBITOR; HEPARIN; PYRIDINE DERIVATIVE; THIAZOLE DERIVATIVE;

ADULT; ANTICOAGULATION; ARTICLE; BLEEDING; BRAIN HEMORRHAGE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DISEASE ASSESSMENT; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEASIBILITY STUDY; FEMALE; HEART INFARCTION; HUMAN; IMAGE ANALYSIS; IMAGE DISPLAY; MAGNETIC RESONANCE VENOGRAPHY; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTICENTER STUDY; NUCLEAR MAGNETIC RESONANCE; OUTCOME ASSESSMENT; PHLEBOGRAPHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SUBDURAL HEMATOMA; VENOUS THROMBOEMBOLISM; AGED; BLOOD CLOTTING; CLINICAL TRIAL; COMBINATION DRUG THERAPY; COMPARATIVE STUDY; DIAGNOSTIC IMAGING; DRUG EFFECTS; INTERNATIONAL NORMALIZED RATIO; INTRAVENOUS DRUG ADMINISTRATION; MAGNETIC RESONANCE ANGIOGRAPHY; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PREDICTIVE VALUE; PROCEDURES; TIME FACTOR; TREATMENT OUTCOME; UNITED STATES; VENOUS THROMBOSIS;

ADMINISTRATION, INTRAVENOUS; ADMINISTRATION, ORAL; ADULT; AGED; ANTICOAGULANTS; BLOOD COAGULATION; DRUG THERAPY, COMBINATION; FACTOR XA INHIBITORS; FEASIBILITY STUDIES; FEMALE; HEPARIN; HUMANS; INTERNATIONAL NORMALIZED RATIO; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; PHLEBOGRAPHY; PREDICTIVE VALUE OF TESTS; PYRIDINES; THIAZOLES; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES; VENOUS THROMBOSIS; WARFARIN;

EID: 84979642707     PISSN: 1358863X     EISSN: 14770377     Source Type: Journal    
DOI: 10.1177/1358863X16645853     Document Type: Article

References (14)

1. Abdalla G, Fawzi Matuk R, Venugopal V, et al. The diagnostic accuracy of magnetic resonance venography in the detection of deep venous thrombosis: A systematic review and meta-analysis. Clin Radiol 2015; 70: 858-871.
2. Enden T, Storas TH, Negard A, et al. Visualization of deep veins and detection of deep vein thrombosis (DVT) with balanced turbo field echo (b-TFE) and contrast-enhanced T1 fast field echo (CE-FFE) using a blood pool agent (BPA). J Magn Reson Imaging 2010; 31: 416-424.
3. Kluge A, Mueller C, Strunk J, et al. Experience in 207 combined MRI examinations for acute pulmonary embolism and deep vein thrombosis. AJR Am J Roentgenol 2006; 186: 1686-1696.
4. Ono A, Murase K, Taniguchi T, et al. Deep venous thrombosis: Diagnostic value of non-contrast-enhanced MR venography using electrocardiography-triggered three-dimensional half-Fourier FSE. Magn Reson Med 2010; 64: 88-97.
5. Sampson FC, Goodacre SW, Thomas SM, et al. The accuracy of MRI in diagnosis of suspected deep vein thrombosis: Systematic review and meta-analysis. Eur Radiol 2007; 17: 175-181.
6. Tan M, Mol GC, van Rooden CJ, et al. Magnetic resonance direct thrombus imaging differentiates acute recurrent ipsilateral deep vein thrombosis from residual thrombosis. Blood 2014; 124: 623-627.
7. Westerbeek RE, Van Rooden CJ, Tan M, et al. Magnetic resonance direct thrombus imaging of the evolution of acute deep vein thrombosis of the leg. J Thromb Haemost 2008; 6: 1087-1092.
8. Mani V, Alie N, Ramachandran S, et al. A multicenter MRI protocol for the evaluation and quantification of deep vein thrombosis. J Vis Exp 2015; (100): e52761.
9. Partovi S, Aschwanden M, Staub D, et al. Gadofosveset enhanced MR phlebography for detecting pelvic and deep vein leg thrombosis. Vasa 2011; 40: 315-319.
10. Agnelli G, Gallus A, Goldhaber SZ, et al. Treatment of proximal deep-vein thrombosis with the oral direct factor Xa inhibitor rivaroxaban (BAY 59-7939): The ODIXa-DVT (Oral Direct Factor Xa Inhibitor BAY 59-7939 in Patients With Acute Symptomatic Deep-Vein Thrombosis) study. Circulation 2007; 116: 180-187.
11. Schulman S, Kearon C,. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost 2005; 3: 692-694.
12. Buller HR, Decousus H, Grosso MA, et al. Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism. N Engl J Med 2013; 369: 1406-1415.
13. Temme S, Grapentin C, Quast C, et al. Noninvasive imaging of early venous thrombosis by 19F magnetic resonance imaging with targeted perfluorocarbon nanoemulsions. Circulation 2015; 131: 1405-1414.
14. Treitl KM, Treitl M, Kooijman-Kurfuerst H, et al. Three-dimensional black-blood T1-weighted turbo spin-echo techniques for the diagnosis of deep vein thrombosis in comparison with contrast-enhanced magnetic resonance imaging: A pilot study. Invest Radiol 2015; 50: 401-408.